Employees at Veristat handle complex work that is both rewarding and meaningful. Our team members are dedicated partners to internal colleagues and external clients alike.
Our values include:
If this sounds like an environment you would thrive in, then click below to learn more about us.
Since the day Veristat was formed, our approach has focused on partnership. We aren’t here to complicate your studies, we are here to be a true extension of your team, to build enduring partnerships, to be a trust-worthy teacher and respected team member.
We are here to be TRUE Partners to You.
Our teams support innovative, life-enhancing, and life-saving therapies that range from novel vaccines for global pandemics to new approaches for treating fungal infections to the latest immunotherapies to eradicate cancer. We have the right expertise and therapeutic understanding and creative know-how to help you design, build, and run your clinical development program in any therapeutic area.
Our core therapeutic Centers of Excellence include: Cancers, Rare Diseases, CNS Disorders, Cardiovascular Disease, Infectious Diseases and more.
Upon receiving approval from Health Canada, Antibe Therapeutics selected Veristat to immediately begin work on part one of a Phase 2B dose-ranging, efficacy study for their lead drug candidate ATB-346. The study will run in Canada and is expected to conclude in December 2018.
In 1964, a child’s chance of surviving the most common form of Leukemia was 3%. Today it has increased to 91%!
